You are here
Price rise for anti-allergy EpiPen sparks furore
A FIVEFOLD price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.
Mylan Pharmaceuticals, which holds a near-monopoly position on the
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org